243 related articles for article (PubMed ID: 35784532)
1. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer.
Xie D; Chen Y; Wan X; Li J; Pei Q; Luo Y; Liu J; Ye T
Front Endocrinol (Lausanne); 2022; 13():916469. PubMed ID: 35784532
[TBL] [Abstract][Full Text] [Related]
2. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
[TBL] [Abstract][Full Text] [Related]
3. Elevated miRNA Inversely Correlates with
Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Significance of
Ye T; Wan X; Li J; Feng J; Guo J; Li G; Liu J
Onco Targets Ther; 2020; 13():199-214. PubMed ID: 32021267
[TBL] [Abstract][Full Text] [Related]
5. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Bertoli G; Cava C; Castiglioni I
Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA LINC00312 regulates breast cancer progression through the miR‑9/CDH1 axis.
Chen Y; Qiu F; Huang L; Liu W; Li L; Ji C; Zeng X; Qiao L; Liu M; Gong X
Mol Med Rep; 2020 Mar; 21(3):1296-1303. PubMed ID: 31894332
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W
Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer.
Yan LR; Wang A; Lv Z; Yuan Y; Xu Q
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439992
[TBL] [Abstract][Full Text] [Related]
11. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
[TBL] [Abstract][Full Text] [Related]
12. Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Zhu XY
Asian Pac J Cancer Prev; 2012; 13(5):1901-6. PubMed ID: 22901144
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
14. Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration.
Yin L; Ding Y; Wang Y; Wang C; Sun K; Wang L
Int J Gen Med; 2023; 16():1279-1294. PubMed ID: 37077765
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-572 targets CDH1 to promote metastasis of Wilms' tumor.
Zhang C; Lv GQ; Cui LF; Guo CC; Liu QE
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3709-3717. PubMed ID: 31114995
[TBL] [Abstract][Full Text] [Related]
16. Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer.
Mamdouh S; Sherif H; Romeih M; Elesaily K
Asian Pac J Cancer Prev; 2023 Jan; 24(1):121-131. PubMed ID: 36708560
[TBL] [Abstract][Full Text] [Related]
17. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
Zhao C; Ling X; Li X; Hou X; Zhao D
Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive analysis of different types of databases reveals that CDH1 mRNA and E-cadherin protein are not downregulated in most carcinoma tissues and carcinoma cell lines.
Sicairos B; Alam S; Du Y
BMC Cancer; 2023 May; 23(1):441. PubMed ID: 37189027
[TBL] [Abstract][Full Text] [Related]
20. miR-205-5p Downregulation and
Kalinkova L; Nikolaieva N; Smolkova B; Ciernikova S; Kajo K; Bella V; Kajabova VH; Kosnacova H; Minarik G; Fridrichova I
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
